Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2018 08:30 ET | Source: Toolgen, Inc.

European Patent Office to Grant ToolGen, Inc. a patent on CRISPR-Cas9 system for genome editing

SEOUL, South Korea, July 31, 2018 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX 199800) announced today that on July 26, 2018 the European Patent Office (EPO) issued a Decision to Grant to ToolGen a...
May 17, 2018 14:48 ET | Source: Toolgen, Inc.

ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells

Knockout of T-Cell suppression pathway improves T-cell anti-tumor activity in a mouse glioblastoma model Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting ...
December 11, 2017 08:30 ET | Source: Toolgen, Inc.

ToolGen, Inc. Demonstrates Potential of CRISPR/cas9 Gene Editing to Overcome T-Cell Immunosuppression

Potential Therapeutic Strategy to Target Tumors that Evade T-Cell Immune Response Data Presented at the 59th American Society of Hematology Annual Meeting SEOUL, South Korea, Dec. 11, 2017 (GLOBE...
November 28, 2017 08:30 ET | Source: Toolgen, Inc.

ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting

SEOUL, South Korea, Nov. 28, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced a poster presentation on its CRISPR...
August 16, 2017 08:30 ET | Source: Toolgen, Inc.

Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for Farmers

ST. LOUIS and SEOUL, South Korea, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Monsanto Company (NYSE:MON) and ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, announced...
May 15, 2017 08:30 ET | Source: Toolgen, Inc.

ToolGen, Inc. Announces Poster Presentation on Genome Editing of Human T Cells at 2017 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting

SEOUL, South Korea, May 15, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, presented results from a study highlighting the use of...
February 22, 2017 08:30 ET | Source: Toolgen, Inc.

ToolGen, Inc. Highlights Study Results Demonstrating Utility of AAV-Compatible Cas9 System in vivo Genome Editing

SEOUL, South Korea, Feb. 22, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced encouraging data from a study evaluating...